Announcements Trials
Browse Landscape

Phase

Phase 2 1Phase 1/2 1

Status

Completed 2

Sponsor Class

INDUSTRY 2

Study Type

Interventional 2

Sponsor

Cancer Type

CNS 2

Conditions

Glioblastoma 3Nervous System Neoplasms 2Nervous System Diseases 2Neoplasms 2Glioma 2Central Nervous System Neoplasms 2Central Nervous System Diseases 2Brain Neoplasms 2Brain Diseases 2Astrocytoma 2Multiple Myeloma 1

Interventions

Temozolomide 17Radiotherapy 8Surgical Procedures, Operative 6Flucytosine 6vocimagene amiretrorepvec 5IL13-PE38 5Lomustine 4Valacyclovir 3Radiation 3Corticotropin-Releasing Hormone 3Chlorotoxin 3Carmustine 3Bevacizumab 3vorasidenib 2trametinib 2tovorafenib 2regorafenib 2pembrolizumab 2paclitaxel-Angiopep-2 conjugate 2dabrafenib 2Trabedersen 2OKN 007 2Nivolumab 2Everolimus 2Eflornithine 2Drug Delivery Systems 2Carboplatin 2Cancer Vaccines 2Adjuvants, Immunologic 2trastuzumab deruxtecan 1

Date Range

30 days90 days1 yearAll

Options

Has results Has announcements

Clinical Trials

2 trials
RecentStart dateEnrollment
INDUSTRY × Astrocytoma × Adjuvants, Immunologic × Clear all
NCT01290692 2023-07-03

Study To Test the Safety and Efficacy of TVI-Brain-1 As A Treatment for Recurrent Grade IV Glioma

TVAX Biomedical

Phase 2 Completed
14 enrolled 11 charts
CNS

Astrocytoma, Brain Diseases, Brain Neoplasms, Central Nervous System Diseases, Glioblastoma, Glioma, Neoplasms, Nervous System Diseases, Nervous System Neoplasms, Central Nervous System Neoplasms

NCT01081223 2023-06-01

Phase I/II Study To Test The Safety and Efficacy of TVI-Brain-1 As A Treatment For Recurrent Grade IV Glioma

TVAX Biomedical

Phase 1/2 Completed
12 enrolled 11 charts
CNS

Astrocytoma, Brain Diseases, Brain Neoplasms, Central Nervous System Diseases, Glioblastoma, Glioma, Neoplasms, Nervous System Diseases, Nervous System Neoplasms, Central Nervous System Neoplasms

Data powered by HemOnc (CC BY 4.0) Colophon âš¡